Table 3. Net cost per cancer prevented (US dollars) for each strategy at varying prevalence rates of H. pylori.
| Net cost per cancer prevented | Prevalence | ||
| Management Options | 25% | 50% | 75% |
| 1) No screening | 0 | 0 | 0 |
| 2) Treat all | 477800 | 206900 | 116600 |
| 3) Screen and Treatment | |||
| a. Serology | |||
| No follow up | 294700 | 169900 | 128300 |
| b. Stool Ag | |||
| No follow up | 219200 | 142700 | 117100 |
| i) Follow with stool Ag and retreat | 193900 | 132300 | 111800 |
| c. Breath test | |||
| No follow up | 360200 | 213800 | 165000 |
| i) Follow with breath test and retreat | 334600 | 216400 | 177000 |
| d. Gastroscopy | |||
| No follow up | 972000 | 520600 | 370200 |
| i) Follow up gastroscopy and retreat | 939900 | 577200 | 456300 |
| ii) Follow with breath test and retreat | 820200 | 460100 | 340100 |
| iii) Follow with stool Ag and retreat | 794400 | 433900 | 313700 |